| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 10/04/2011 | US8030285 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent |
| 10/04/2011 | US8030284 Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAs |
| 10/04/2011 | US8030277 Polypeptide and gene encoding the same |
| 10/04/2011 | US8030096 Water-soluble rhodamine dyes conjugates |
| 10/04/2011 | US8030060 Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer |
| 10/04/2011 | US8030053 Substitutional variants of hydroxynitrile lyase with high specific activity and methods of use |
| 10/04/2011 | US8030052 Midecamycin hyper producing strain |
| 10/04/2011 | US8030050 Pseudomonal, heat resistant amylase for use as additive in animal feeds; enhancing firmness, cohesiveness and resilience food products |
| 10/04/2011 | US8030049 Galactosidase with α-galactosyltransferase activity |
| 10/04/2011 | US8030045 Beta-alanine/alpha-ketoglutarate aminotransferase for 3-hydroxypropionic acid production |
| 10/04/2011 | US8030044 Lipid acyltransferases |
| 10/04/2011 | US8030043 β-galactoside-α2,3-sialyltransferase, a gene encoding thereof, and a method for producing thereof |
| 10/04/2011 | US8030042 Polyamino acid synthetase and gene encoding the same |
| 10/04/2011 | US8030038 Stabilization of perhydrolases |
| 10/04/2011 | US8030036 Method for producing L-lysine or L-threonine |
| 10/04/2011 | US8030031 Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer |
| 10/04/2011 | US8030028 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 10/04/2011 | US8030026 Antibodies to troponin I and methods of use thereof |
| 10/04/2011 | US8030016 Method for screening for vitamin D receptor ligands |
| 10/04/2011 | US8030009 Human T2R67 taste receptor and related assays for identifying human bitter taste modulators |
| 10/04/2011 | US8029997 Methods of analysis of allelic imbalance |
| 10/04/2011 | US8029996 Method for the determination of cystosine methylation in CpG islands |
| 10/04/2011 | US8029993 Asymmetric adapter library construction |
| 10/04/2011 | US8029991 Method and formulation for the extraction of nucleic acids from any complex starting materials |
| 10/04/2011 | US8029988 Oligonucleotide mediated nucleic acid recombination |
| 10/04/2011 | US8029987 Method for detecting C. albicans |
| 10/04/2011 | US8029984 Materials and methods for colorectal cancer screening, diagnosis and therapy |
| 10/04/2011 | US8029806 Method for diagnosing of Mycobacterium tuberculosis |
| 10/04/2011 | US8029789 Method for the mass production of immunoglobulin constant region |
| 10/04/2011 | US8029776 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 10/04/2011 | CA2480308C Antisense iap nucleobase oligomers and uses thereof |
| 10/04/2011 | CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 09/29/2011 | WO2011119937A1 The isolation and use of fad2 and fae1 from camelina |
| 09/29/2011 | WO2011119887A1 Rna interference in dermal and fibrotic indications |
| 09/29/2011 | WO2011119871A1 Rna interference in ocular indications |
| 09/29/2011 | WO2011119852A1 Reduced size self-delivering rnai compounds |
| 09/29/2011 | WO2011119553A1 Materials and methods related to modulation of mismatch repair and genomic stability by mir-155 |
| 09/29/2011 | WO2011117353A1 Bivalent antisense oligonucleotides |
| 09/29/2011 | WO2011116456A1 Methods and compositions for the detection and identification of archaea based on the type ii chaperonin (thermosome) gene |
| 09/29/2011 | WO2011097644A3 Selective reduction of allelic variants |
| 09/29/2011 | WO2011082253A3 A method to produce acetyldiacylglycerols (ac-tags) by expression ofan acetyltransferase gene isolated from euonymus alatus (burning bush) |
| 09/29/2011 | WO2011002200A3 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof |
| 09/29/2011 | US20110239333 Polypeptides Having Xylanase Activity And Polynucleotides Thereof |
| 09/29/2011 | US20110239331 Insecticidal Compounds and Methods for Selection Thereof |
| 09/29/2011 | US20110239329 Secondary Wall Forming Genes from Maize and Uses Thereof |
| 09/29/2011 | US20110239328 SWEETPOTATO SRD1 cDNA AND TRANSGENIC PLANTS WITH HIGH-NUMBERED STORAGE ROOTS USING THE SAME |
| 09/29/2011 | US20110239326 Hybrid-type histidine kinase gene isolated from indica rice ir64 |
| 09/29/2011 | US20110239325 Polynucleotide sequence of fruit softening associated a-mannosidase and its uses for enhancing fruit shelf life |
| 09/29/2011 | US20110239324 Production of Plants with Decreased Nitrite Content |
| 09/29/2011 | US20110239323 Isolation and use of fad2 and fae1 from camelina |
| 09/29/2011 | US20110239321 Herbicide tolerant soybean plants and methods for identifying same |
| 09/29/2011 | US20110239319 Use of Endonucleases for Inserting Transgenes Into Safe Harbor Loci |
| 09/29/2011 | US20110239316 ANTI-cMET ANTIBODY |
| 09/29/2011 | US20110239315 Modular dna-binding domains and methods of use |
| 09/29/2011 | US20110239314 Gene of porcine alpha-si casein, a promoter of the same and use thereof |
| 09/29/2011 | US20110239311 Agonists of NR2F6 For Immunosupression |
| 09/29/2011 | US20110237787 High throughput nucleic acid sequencing by expansion |
| 09/29/2011 | US20110237786 Method for preparing oligonucleotide |
| 09/29/2011 | US20110237779 Cdr-repaired antibodies |
| 09/29/2011 | US20110237657 Transport-Mediating Colloidal Pharmaceutical Compounds |
| 09/29/2011 | US20110237655 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 09/29/2011 | US20110237654 Method to inhibit cell growth using oligonucleotides |
| 09/29/2011 | US20110237651 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo |
| 09/29/2011 | US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf |
| 09/29/2011 | US20110237649 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1 |
| 09/29/2011 | US20110237648 Rna interference in skin indications |
| 09/29/2011 | US20110237647 Inhibitory rna for modulating the molecular function of zfat gene |
| 09/29/2011 | US20110237645 USE OF RNAi TECHNOLOGY TO INHIBIT ASIC3 |
| 09/29/2011 | US20110237643 Identification of a Novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity |
| 09/29/2011 | US20110237521 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 09/29/2011 | US20110237518 Method for treating or preventing bladder cancer using the depdc1 polypeptide |
| 09/29/2011 | US20110237515 Peptide derived from neurotesin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 09/29/2011 | US20110237501 Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1 |
| 09/29/2011 | US20110237500 Cecropin-magainin hybrid peptides |
| 09/29/2011 | US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| 09/29/2011 | US20110237454 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same |
| 09/29/2011 | US20110237453 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same |
| 09/29/2011 | US20110237452 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same |
| 09/29/2011 | US20110237448 Carbohydrate binding module with affinity for insoluble xylan |
| 09/29/2011 | US20110236991 Aptamer-Based Colorimetric Sensor Systems |
| 09/29/2011 | US20110236972 Nucleic acid compounds for inhibiting birc5 gene expression and uses thereof |
| 09/29/2011 | US20110236969 Methods of generating variant proteins with increased host string content and compositions thereof |
| 09/29/2011 | US20110236968 Humanized antibodies against monocyte chemotactic proteins |
| 09/29/2011 | US20110236957 Nanoparticle Labeling Reagents and Methods of Use |
| 09/29/2011 | US20110236956 MULTICISTRONIC siRNA CONSTRUCTS TO INHIBIT TUMORS |
| 09/29/2011 | US20110236920 Novel variants of pqq-dependent glucose dehydrogenase having improved substrate specificity |
| 09/29/2011 | US20110236900 Novel muts protein and method for determing mutation using the same |
| 09/29/2011 | US20110236898 Methods for enhancing nucleic acid hybridization |
| 09/29/2011 | US20110236897 Novel markers for diagnosing brain disease caused by brain injury and use thereof |
| 09/29/2011 | US20110236893 Lgr5 modulators in the treatment of alopecia |
| 09/29/2011 | US20110236892 Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay |
| 09/29/2011 | US20110236886 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 09/29/2011 | US20110236883 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification |
| 09/29/2011 | US20110236531 Glyceroglycolipid lipase |
| 09/29/2011 | US20110236484 Genus-Wide Chlamydial Peptide Vaccine Antigens |
| 09/29/2011 | US20110236483 Rna vector therapy |
| 09/29/2011 | US20110236470 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS |
| 09/29/2011 | US20110236467 Method for erectile function potentiation by pharmaceutical compositions comprising toxin tx2-6 of the spider phoneutria nigriventer |
| 09/29/2011 | US20110236429 Small Cationic Antimicrobial Peptides |
| 09/29/2011 | US20110236427 Antagonists of NR2F6 For Augmenting The Immune Response |